445 related articles for article (PubMed ID: 23795222)
21. Analysis of complementarities between nanomedicine and phytodrugs for the treatment of malarial infection.
Fulgheri F; Manca ML; Fernàndez-Busquets X; Manconi M
Nanomedicine (Lond); 2023 Oct; 18(23):1681-1696. PubMed ID: 37955573
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticles in clinical trials of COVID-19: An update.
Rauf A; Abu-Izneid T; Khalil AA; Hafeez N; Olatunde A; Rahman M; Semwal P; Al-Awthan YS; Bahattab OS; Khan IN; Khan MA; Sharma R
Int J Surg; 2022 Aug; 104():106818. PubMed ID: 35953020
[TBL] [Abstract][Full Text] [Related]
23. Algal-derived nanoparticles and their antibacterial potential: Current evidence and future prospectives.
Mandal AK; Nayak R; Pradhan B; Behera C; Behera AK; Parida S; Patra S; Hembram P; Jena M
J Microbiol Methods; 2023 Aug; 211():106790. PubMed ID: 37487886
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities.
Abdel-Mageed HM; AbuelEzz NZ; Radwan RA; Mohamed SA
J Microencapsul; 2021 Sep; 38(6):414-436. PubMed ID: 34157915
[TBL] [Abstract][Full Text] [Related]
25. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.
Sousa de Almeida M; Susnik E; Drasler B; Taladriz-Blanco P; Petri-Fink A; Rothen-Rutishauser B
Chem Soc Rev; 2021 May; 50(9):5397-5434. PubMed ID: 33666625
[TBL] [Abstract][Full Text] [Related]
26. Advances in nanomedicines for malaria treatment.
Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
[TBL] [Abstract][Full Text] [Related]
27. Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health.
Zhang J; Hu K; Di L; Wang P; Liu Z; Zhang J; Yue P; Song W; Zhang J; Chen T; Wang Z; Zhang Y; Wang X; Zhan C; Cheng YC; Li X; Li Q; Fan JY; Shen Y; Han JY; Qiao H
Adv Drug Deliv Rev; 2021 Nov; 178():113964. PubMed ID: 34499982
[TBL] [Abstract][Full Text] [Related]
28. Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease.
Woon CK; Hui WK; Abas R; Haron MH; Das S; Lin TS
Curr Neuropharmacol; 2022; 20(8):1498-1518. PubMed ID: 34923947
[TBL] [Abstract][Full Text] [Related]
29. Vascular Nanomedicine: Current Status, Opportunities, and Challenges.
Sun M; Sen Gupta A
Semin Thromb Hemost; 2020 Jul; 46(5):524-544. PubMed ID: 31200393
[TBL] [Abstract][Full Text] [Related]
30. Understanding the mechanisms of silica nanoparticles for nanomedicine.
Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
[TBL] [Abstract][Full Text] [Related]
31. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
[TBL] [Abstract][Full Text] [Related]
32. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
33. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicine for drug delivery in South Africa: a protocol for systematic review.
Saidi T; Fortuin J; Douglas TS
Syst Rev; 2018 Oct; 7(1):154. PubMed ID: 30292237
[TBL] [Abstract][Full Text] [Related]
35. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
Shi J; Xiao Z; Kamaly N; Farokhzad OC
Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
[TBL] [Abstract][Full Text] [Related]
36. Cancer nanomedicine: from targeted delivery to combination therapy.
Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O
Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384
[TBL] [Abstract][Full Text] [Related]
37. Innovative Applications of Plant Viruses in Drug Targeting and Molecular Imaging- A Review.
Aljabali AAA; Al Zoubi MS; Al-Batayneh KM; Pardhi DM; Dua K; Pal K; Tambuwala MM
Curr Med Imaging; 2021; 17(4):491-506. PubMed ID: 33030133
[TBL] [Abstract][Full Text] [Related]
38. Nanomedicine as a promising strategy for the theranostics of infectious diseases.
Liu H; Zhong W; Zhang X; Lin D; Wu J
J Mater Chem B; 2021 Oct; 9(38):7878-7908. PubMed ID: 34611689
[TBL] [Abstract][Full Text] [Related]
39. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
40. Exploring the potential of antimalarial nanocarriers as a novel therapeutic approach.
Deshmukh R
J Mol Graph Model; 2023 Jul; 122():108497. PubMed ID: 37149980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
